Current Antiplatelet Treatment Strategy in Patients with Diabetes Mellitus

Patients with diabetes mellitus (DM) have accelerated atherosclerosis with an increased risk for atherothrombotic cardiovascular complications. A state of high platelet reactivity and activation, hypercoagulability (prothrombotic state) and a subdued response to standard antiplatelet agents may expl...

Descripción completa

Detalles Bibliográficos
Autores principales: Jung, Jung Hwa, Tantry, Udaya S., Gurbel, Paul A., Jeong, Young-Hoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Diabetes Association 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4411553/
https://www.ncbi.nlm.nih.gov/pubmed/25922803
http://dx.doi.org/10.4093/dmj.2015.39.2.95

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4411553/
https://www.ncbi.nlm.nih.gov/pubmed/25922803
http://dx.doi.org/10.4093/dmj.2015.39.2.95

Ejemplares similares